Compound E, chemically designated as the compound 209986-17-4, represents a significant investigation within the field of Alzheimer's disease research. This γ-secretase modulator was initially developed as a https://sachinntsx012141.mpeblog.com/73289356/γ-secretase-blocker-compound-e-209986-17-4